Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
US8952014B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8952014-B2 |
| Application number | US-200913140607-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 17, 2009 |
| Priority date | Dec 19, 2008 |
| Publication date | Feb 10, 2015 |
| Grant date | Feb 10, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the new compounds of general formula I wherein A, U, V, X, Y, R 1 , R 2 and R 3 are defined as stated hereinafter, the tautomers, the isomers thereof, the diastereomers, the enantiomers, the hydrates, the mixtures and the salts thereof as well as the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, medicaments containing these compounds, their use and processes for preparing them.
Opening claim text (preview).
The invention claimed is: 1. A compound of the formula wherein A denotes —NH, —N(C(O)—C 1-3 -alkyl), S, O, SO, SO 2 , R 1 and R 2 together with the nitrogen atom to which they are attached denote a moiety selected from the group consisting of…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.